Tree-Based Methods for Discovery of Association between Flow Cytometry Data and Clinical Endpoints

Table 2

Univariate associations with CD4+ count at 36 weeks on ART.

Predictor	Odds ratio	P-value
CD3-DR-CD56+CD16+	0.183	.008
Lin-DR-	0.228	.018
CD45+CD3+	0.274	.035
CD3+CD8+CD38+CD28+	0.281	.047
CD3-CD8+	0.323	.084
CD3-DR+CD56+CD16+	0.339	.087
CD3+CD8-CD7+CD154+	0.339	.087
CD3-DR-CD56-CD16-	0.364	.113
CD3+CD8+CD7+CD154+	0.388	.463
CD3+CD8-CD7+CD154-	0.389	.146
CD3+CD8-DR+CD95-	0.429	.189
CD3+DR-	0.460	.236
CD3+CD8-CD45RA+CD62L+	0.477	.283
CD3+CD8-DR+CD95+	0.477	.283
CD45-CD3+	0.494	.632
CD3+CD8-	0.494	.632
Lin-DR+CD123+CD11c+	0.564	.424
CD3+CD8+DR+CD95+	0.628	.571
CD3-DR+	0.646	.586
CD3+CD8-DR-CD95-	0.646	.586
CD45+CD3+CD8-CD4-	0.703	.690
CD3+CD8+CD38-CD28+	0.709	.699
CD3+CD8-CD7-CD154-	0.740	.774
CD3+CD8+	0.752	.786
CD3+CD8-CD38+CD28+	0.759	.797
CD3+CD8+CD38+CD28-	0.760	.812
CD3-DR+CD56-CD16-	0.805	.887
CD3-DR+CD56+CD16-	0.805	.887
CD3+CD8+CD38-CD28-	0.813	.898
CD45-CD3-	0.862	.989
Lin-DR+CD123+CD11c-	0.913	.917
CD3+CD8+CD45RA+CD62L-	0.923	.908
CD3+CD8+CD45RA-CD62L	0.931	.898
CD45+CD3+CD8-CD4+	0.931	.898
CD3+CD8+DR+CD95-	0.938	.887
CD3+CD8-CD7-CD154+	0.962	.696
CD3+CD8-CD38+CD28-	0.996	.797
CD3+CD8+DR-CD95-	1.004	.797
Lin+DR+	1.074	.898
CD3-DR-CD56-CD16+	1.074	.898
CD3-CD8-	1.074	.898
Lin+DR-	1.149	1.000
CD45+CD3-	1.160	.989
CD3+CD8-CD38-CD28-	1.160	.989
CD3+CD8-CD45RA+CD62L-	1.230	.898
CD45+CD3+CD8+CD4-	1.317	.797
CD3+DR+	1.329	.786
Lin-DR+CD123-CD11c-	1.329	.786
CD3+CD8-DR-CD95+	1.329	.786
CD3+CD8+DR-CD95+	1.410	.699
CD45+CD3+CD8+CD4+	1.410	.699
CD3+CD8+CD45RA-CD62L+	1.422	.690
CD3-DR-	1.446	.677
CD3-DR+CD56-CD16+	1.486	.661
Lin-DR+	1.511	.605
CD4+	1.522	.598
Lin-DR+CD123-CD11c+	1.522	.598
CD3+CD8-CD45RA-CD62L+	1.630	.512
CD3-DR-CD56+CD16-	1.630	.512
CD3+CD8+CD7+CD154-	1.657	.502
CD3+CD8+CD7-CD154-	1.707	.487
CD3+CD8-CD38-CD28+	1.898	.354
CD3+CD8-CD45RA-CD62L	2.011	.294
CD3+CD8+CD45RA+CD62L+	2.152	.238